Drugs Controller General of India (DCGI) has directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate...
from NDTV News - Special https://ift.tt/2Fksy5W
Subscribe to:
Post Comments (Atom)
Zepto gets Sebi’s nod for $1bn IPO
from Business News Today: Stock Markets, Financial News, India Business & World Business News https://ift.tt/hTbufz5
-
China has emerged as a significant player in AI foundation models with DeepSeek, creating powerful AI models at lower costs than the West. T...
-
Nigeria's President Buhari on Sunday denied claims that he had died and been replaced by a Sudanese impostor, breaking his silence on a ...
-
Meng Wanzhou, the high-profile top executive of telecom giant Huawei who was detained in Canada for over three years, received a hero's ...
No comments:
Post a Comment